SCHEMBL17864798

SCHEMBL17864798

c1ccc(-c2c(-c3c(-c4ccccc4)c4ccccc4c4ccccc34)ccc3cc(-c4cccc(-c5c6ccccc6c(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)c6ccccc56)c4)ccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ HSD17B1 P14061 9/20 0.38
▸ HSD17B2 P37059 9/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ CYP2D6 P10635 3/20 0.38
▸ CYP2C9 P11712 3/20 0.38
▸ CYP2B6 P20813 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ ESR1 P03372 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALOX5 P09917 1/20 0.33
▸ PTGER4 P35408 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ TSPO P30536 1/20 0.31
▸ IL1R1 P14778 1/20 0.31
▸ MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17864666 0.97 L3MBTL1 (0.43) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL13233170 0.87 L3MBTL1 (0.43) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL13233171 0.86 L3MBTL1 (0.44) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL12400938 0.84 L3MBTL1 (0.56) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL15461364 0.84 L3MBTL1 (0.56) L3MBTL1KDM4EATMKMT2APTGER4
SCHEMBL24004110 0.84 KDM4E (0.44) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL17718053 0.84 L3MBTL1 (0.44) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL13147443 0.83 L3MBTL1 (0.46) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL124876 0.83 L3MBTL1 (0.49) L3MBTL1KDM4EATMHSD17B1HSD17B2
SCHEMBL12400925 0.83 L3MBTL1 (0.49) L3MBTL1KDM4EATMHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181543-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE RER1, LEF1, RPL18 L3MBTL1 757/4885KDM4E 3259/4885ATM 3284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback